The introduction of nicotinamide as being a nicotine substitute in e-cigarette and smokeless goods signifies an important regulatory challenge with the FDA. Nicotinamide does not have nicotinic receptor agonist activity and is thought to work as a sedative at substantial dosages6. The promises made by Nicotine River, ECBlend, along with other vendo